NPCE — NeuroPace, Inc. stock price, charts and financials

QT42NeuroPace, Inc.

NeuroPace, Inc. (NASDAQ: NPCE) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
14.14
+0.64+4.74%
OverviewShort InterestFilings
NPCEQT42NeuroPace, Inc.·NASDAQ
14.14+4.74%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 28, 20268-KCurrent report
Jun 25, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 08, 20268-KCurrent report
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 12, 20268-KCurrent report
May 12, 202610-QQuarterly report
Apr 21, 2026DEFA14AAdditional proxy soliciting materials
Apr 21, 2026ARSAnnual report to shareholders
Apr 21, 2026DEF 14ADefinitive proxy statement
#1 / 25 of 271
Page
▼
/ 11